Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03418350 · ClinicalTrials.gov registry record
The Role of Laryngopharyngeal Reflux in IPF
A clinical trial of IPF and Reflux, sponsored by National Jewish Health.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT03418350: Recruiting study of IPF and Reflux, sponsored by National Jewish Health.
NCT03418350 is a study of IPF and Reflux that is actively recruiting participants, run by National Jewish Health. The registered enrollment target is 60 participants, below the 275-participant average among 3 other IPF trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03418350, a study of IPF and Reflux, is actively recruiting participants, sponsored by National Jewish Health.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).
Primary Outcome
Correlation between the supraglottic index and forced vital capacity. The supraglottic index is an index derived by assigning scores for edema and erythema of five supraglottic structures (epiglottis, false cords, arytenoids, posterior commissure, piriform recess) as viewed through a fiber-optic scope. Scores range from 0-22, with higher scores indicating more severe LPR.
Study Locations (1)
Colorado
- National Jewish Health - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2026-12 |
What NCT03418350 shows while recruiting
NCT03418350 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 275-participant average among 3 other IPF trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with IPF appearing as the primary indexed condition, and to 0 interventions.
NCT03418350 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03418350 about?
NCT03418350 is a clinical study titled "The Role of Laryngopharyngeal Reflux in IPF". The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).
What is the current status of trial NCT03418350?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2018-08-01. Estimated completion is 2026-12.
What conditions does trial NCT03418350 study?
This clinical trial studies the following conditions: IPF, Reflux.
Who is sponsoring clinical trial NCT03418350?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03418350 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for IPF
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI